Nasdaq

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in ...
zacks

Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu

Bio-Techne Corp. (TECH Quick Quote TECH - Free Report) recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the ...
WNCT

BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA ...

MINNEAPOLIS, May 10, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic ...
Nasdaq

Bio-Techne Announces Commercial Release of RNAscope™ HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and ...

MINNEAPOLIS, July 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ ...
zacks

Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions

Bio-Techne unveiled RNAscope and COMET advances in spatial biology for clinical utility workflows. TECH shares climbed 2.7% to $51.85 after the Sept. 26 announcement of these innovations. TECH's ...